Jeffrey L. Wade
2006
In 2006, Jeffrey L. Wade earned a total compensation of $668.6K as Executive Vice President and General Counsel at Lexicon Pharmaceuticals.
Compensation breakdown
| Bonus | $80,000 |
|---|---|
| Option Awards | $290,675 |
| Salary | $292,000 |
| Other | $5,920 |
| Total | $668,595 |
Wade received $292K in salary, accounting for 44% of the total pay in 2006.
Wade also received $80K in bonus, $290.7K in option awards and $5.9K in other compensation.
Rankings
In 2006, Jeffrey L. Wade's compensation ranked 3,973rd out of 7,022 executives tracked by ExecPay. In other words, Wade earned more than 43.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,973 out of 7,022 | 43rd |
Division Manufacturing | 1,300 out of 2,413 | 46th |
Major group Chemicals And Allied Products | 316 out of 673 | 53rd |
Industry group Drugs | 207 out of 518 | 60th |
Industry Pharmaceutical Preparations | 156 out of 355 | 56th |
Source: SEC filing on March 13, 2009.
Wade's colleagues
We found four more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2006.
2006
Arthur Sands
Lexicon Pharmaceuticals
Chief Executive Officer
2006
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2006
Julia Gregory
Lexicon Pharmaceuticals
Chief Financial Officer
2006
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019